Caption Management LLC Acquires New Position in Nutrien Ltd. (NYSE:NTR)

Caption Management LLC bought a new position in shares of Nutrien Ltd. (NYSE:NTR - Free Report) during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund bought 49,500 shares of the company's stock, valued at approximately $2,215,000.

A number of other hedge funds also recently modified their holdings of NTR. Cetera Investment Advisers lifted its holdings in Nutrien by 35.9% in the fourth quarter. Cetera Investment Advisers now owns 37,312 shares of the company's stock valued at $1,669,000 after buying an additional 9,863 shares during the period. Balyasny Asset Management L.P. increased its stake in shares of Nutrien by 93.4% during the 4th quarter. Balyasny Asset Management L.P. now owns 17,995 shares of the company's stock worth $805,000 after purchasing an additional 8,690 shares during the last quarter. Bayesian Capital Management LP bought a new position in Nutrien in the 4th quarter valued at $201,000. Bank of America Corp DE boosted its holdings in Nutrien by 5.9% in the 4th quarter. Bank of America Corp DE now owns 2,685,886 shares of the company's stock valued at $120,193,000 after purchasing an additional 150,464 shares during the period. Finally, American Trust Investment Advisors LLC boosted its holdings in Nutrien by 33.0% in the 4th quarter. American Trust Investment Advisors LLC now owns 14,860 shares of the company's stock valued at $665,000 after purchasing an additional 3,690 shares during the period. Institutional investors and hedge funds own 63.10% of the company's stock.

Nutrien Price Performance

Shares of NYSE NTR traded down $0.03 during midday trading on Monday, reaching $55.60. The stock had a trading volume of 892,525 shares, compared to its average volume of 2,442,075. The company has a debt-to-equity ratio of 0.38, a quick ratio of 0.82 and a current ratio of 1.27. The stock has a 50-day moving average of $51.97 and a 200-day moving average of $49.98. Nutrien Ltd. has a 12-month low of $43.69 and a 12-month high of $60.87. The company has a market capitalization of $27.15 billion, a price-to-earnings ratio of 40.58, a price-to-earnings-growth ratio of 1.19 and a beta of 0.79.

Nutrien (NYSE:NTR - Get Free Report) last released its quarterly earnings data on Wednesday, May 7th. The company reported $0.11 EPS for the quarter, missing the consensus estimate of $0.35 by ($0.24). The business had revenue of $4.67 billion for the quarter, compared to the consensus estimate of $5.16 billion. Nutrien had a net margin of 2.62% and a return on equity of 6.81%. Nutrien's revenue for the quarter was down 5.4% compared to the same quarter last year. During the same quarter last year, the business earned $0.46 EPS. As a group, research analysts anticipate that Nutrien Ltd. will post 3.72 EPS for the current fiscal year.

Nutrien Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Friday, July 18th. Stockholders of record on Monday, June 30th will be given a $0.545 dividend. This represents a $2.18 dividend on an annualized basis and a dividend yield of 3.92%. The ex-dividend date is Monday, June 30th. Nutrien's payout ratio is currently 203.74%.

Analyst Upgrades and Downgrades

Several research firms have weighed in on NTR. Wells Fargo & Company boosted their price target on shares of Nutrien from $53.00 to $56.00 and gave the stock an "equal weight" rating in a research note on Friday, February 21st. Berenberg Bank boosted their price target on shares of Nutrien from $54.00 to $59.00 and gave the company a "buy" rating in a research report on Tuesday, April 15th. Barclays boosted their price objective on shares of Nutrien from $56.00 to $59.00 and gave the stock an "equal weight" rating in a research note on Wednesday, March 5th. CIBC boosted their price objective on shares of Nutrien from $64.00 to $66.00 and gave the stock an "outperformer" rating in a research note on Tuesday, February 25th. Finally, UBS Group upped their target price on shares of Nutrien from $52.00 to $56.00 and gave the stock a "neutral" rating in a research note on Thursday. Two analysts have rated the stock with a sell rating, five have issued a hold rating, eight have issued a buy rating and one has assigned a strong buy rating to the company. Based on data from MarketBeat, the company has an average rating of "Moderate Buy" and a consensus target price of $59.93.

Nutrien Profile

Nutrien Ltd. provides crop inputs and services. The company operates through four segments: Retail, Potash, Nitrogen, and Phosphate. The Retail segment distributes crop nutrients, crop protection products, seeds, and merchandise products. The Potash segment provides granular and standard potash products.